Arquivos do dia: Novembro 10, 2021
Estudo randomizado | Vacina da Pfizer mostra 90,7% de eficácia na prevenção de Covid-19 em crianças de 5 a 11 anos de idade.
10 Nov, 2021 | 12:55h
Comentário no Twitter
In this multi-phase trial, two 10-μg doses of the BNT162b2 vaccine administered 21 days apart were safe, immunogenic, and 90.7% effective against #COVID19 in 5-to-11-year-old children. #Covid19vaccine https://t.co/kuj2eI4YCE pic.twitter.com/BWEkYxn8a0
— NEJM (@NEJM) November 9, 2021
Como um surto se tornou uma pandemia: análise cronológica de conjunturas cruciais e obrigações internacionais nos meses iniciais da pandemia de COVID-19.
10 Nov, 2021 | 12:53h
Comentário no Twitter
NEW—How an outbreak became a pandemic: an analysis of the early months of #COVID19 by @TheIndPanel.
Authors point to reform & offer a framework for robust future #pandemic preparedness & response. https://t.co/MlW6zXj2Dn @sudhvir pic.twitter.com/rgHu1QggNQ
— The Lancet (@TheLancet) November 9, 2021
[Preprint] Estudo randomizado | Em pacientes com COVID-19 com hipoxemia, mas não críticos, uma intervenção para estimular o decúbito em prona não melhorou os desfechos.
10 Nov, 2021 | 12:52hRCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv
Conteúdos relacionados:
RCT: Awake prone positioning reduces the need for intubation in patients with COVID-19.
Comentário do autor no Twitter (fio – clique para saber mais)
The results from the COVID-PRONE pragmatic RCT are available @medRxiv! This was a massive team effort with my co-PIs @AmolAVerma, @drfahadrazak. Our goal was to evaluate the effectiveness of prone positioning for pts hospitalized with COVID19. https://t.co/6SpjdPvT2U 🧵 1/5 pic.twitter.com/WH10ciBn4w
— Michael Fralick (@FralickMike) November 8, 2021
Autoridade de saúde da França faz recomendações contra o uso da vacina da Moderna em menores de 30 anos de idade.
10 Nov, 2021 | 12:50hFrench Health Authority Advises Against Moderna COVID-19 Vaccine for Under 30s – Reuters
Ver também: France advises against Moderna for under-30s over rare heart risk – Associated Press
Conteúdo relacionado: Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.
Comentário no Twitter
France's public health authority has recommended people under 30 be given Pfizer's Comirnaty COVID-19 vaccine when available instead of Moderna Inc's Spikevax jab, which carried comparatively higher risks of heart-related problems. https://t.co/4gPTXzEsw0
— Reuters Health (@Reuters_Health) November 9, 2021
Opinião | Imunidade após recuperação de infecção por SARS-CoV-2.
10 Nov, 2021 | 12:48hProtective immunity after recovery from SARS-CoV-2 infection – The Lancet Infectious Diseases
Comentário no Twitter
"Policy makers should consider recovery from previous SARS-CoV-2 infection equal to immunity from vaccination for purposes related to entry to public events, businesses, and the workplace,or travel requirements"
Do you agree with this?
I don't #IDtwitter https://t.co/FHbgXILD8Z— Antibiotic Stewa®️x🆔 Bassam Ghanem (@ABsteward) November 9, 2021
Um proeminente virologista alerta que a nova pílula contra COVID-19 pode gerar perigosas mutações no vírus. Outros não veem com tanto alarde.
10 Nov, 2021 | 12:47hPonto de vista original: Supercharging New Viral Variants: The Dangers Of Molnupiravir (Part 1) – Forbes
Conteúdos relacionados:
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Consenso | Exames de imagem não invasivos em síndromes coronarianas.
10 Nov, 2021 | 12:45hConsenso | Multimodalidade de exames de imagem em pacientes com insuficiência cardíaca e fração de ejeção preservada.
10 Nov, 2021 | 12:44hDiretriz | Tratamento não farmacológico de sintomas persistentes pós-concussão em adultos.
10 Nov, 2021 | 12:43hComentário convidado: Advances in Clinical Management of Persistent Postconcussion Symptoms—The Danish National Clinical Guideline – JAMA Network Open
Comentário no Twitter
Based on low certainty of evidence or based on consensus, new guideline provides recommendations for commonly applied non-pharmacological interventions to treat persistent post-concussion symptoms in adults. https://t.co/CM1pbMqRXN
— JAMA Network Open (@JAMANetworkOpen) November 9, 2021
Estudo randomizado | Rastreamento com sigmoidoscopia flexível uma única vez está associado com redução, no longo prazo, da incidência e mortalidade por câncer colorretal.
10 Nov, 2021 | 12:41hComentários: